Molecular Code Stacks Now in the Payers’ Bull’s Eye
LIKE A STEAM BOILER READY TO EXPLODE FROM TOO MUCH PRESSURE, the nation’s health insurers have reached a point of no return on the subject of code-stacked claims for genetic testing and molecular diagnostics assays. Simply put, payers are ready to tackle this sensitive issue. Payers have reasonable questions about this type of clinical lab …
Molecular Code Stacks Now in the Payers’ Bull’s Eye Read More »